Sign Up to like & get
recommendations!
0
Published in 2020 at "Heliyon"
DOI: 10.1016/j.heliyon.2020.e03352
Abstract: This study was designed to evaluate the effects of DS37001789, a novel and highly potent urotensin II (U-II) receptor (GPR14) antagonist, against mortality, hypertrophy, and cardiac dysfunction in pressure-overload hypertrophy by transverse aortic constriction (TAC)…
read more here.
Keywords:
ds37001789;
pressure overload;
heart failure;